We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Eastern Bankshares
EBC
$5.29B
| $1.12M | ﹤0.01% |
60,779
-20,896
| -26% | -$405K |
|
1377
Malibu Boats
MBUU
$583M
| $1.12M | ﹤0.01% |
21,195
+7,120
| +51% | +$387K |
|
1378
RPM International
RPM
$14.9B
| $1.11M | ﹤0.01% |
14,265
-7,246
| -34% | -$609K |
|
1379
Cactus
WHD
$5.78B
| $1.11M | ﹤0.01% |
27,542
+6,497
| +31% | +$327K |
|
1380
Franklin Electric
FELE
$4.77B
| $1.11M | ﹤0.01% |
15,129
-4,462
| -23% | -$331K |
|
1381
Donnelley Financial Solutions
DFIN
$1.16B
| $1.1M | ﹤0.01% |
37,735
-5,891
| -14% | -$175K |
|
1382
Liberty Latin America Class C
LILAK
$1.66B
| $1.1M | ﹤0.01% |
156,038
+12,067
| +8% | +$100K |
|
1383
Vulcan Materials
VMC
$37.3B
| $1.1M | ﹤0.01% |
7,890
-13,997
| -64% | -$2.31M |
|
|
SEM
1384
DELISTED
Select Medical
SEM
| $1.1M | ﹤0.01% |
86,332
-41,717
| -33% | -$535K |
|
1385
Comfort Systems
FIX
$59.4B
| $1.1M | ﹤0.01% |
13,201
-409
| -3% | -$35.2K |
|
1386
Phillips Edison & Co
PECO
$5.1B
| $1.1M | ﹤0.01% |
+32,865
| New | +$1.12M |
|
1387
EXL Service
EXLS
$5.29B
| $1.1M | ﹤0.01% |
37,220
-73,790
| -66% | -$2.09M |
|
1388
Alamo Group
ALG
$2.07B
| $1.09M | ﹤0.01% |
9,377
+2,608
| +39% | +$320K |
|
1389
Uber
UBER
$160B
| $1.08M | ﹤0.01% |
53,506
+13,076
| +32% | +$347K |
|
1390
Dorman Products
DORM
$3.95B
| $1.08M | ﹤0.01% |
9,806
+519
| +6% | +$51.4K |
|
1391
Protolabs
PRLB
$2.16B
| $1.07M | ﹤0.01% |
22,457
-2,790
| -11% | -$129K |
|
1392
QCR Holdings
QCRH
$1.71B
| $1.07M | ﹤0.01% |
19,857
+306
| +2% | +$16.7K |
|
1393
RLJ Lodging Trust
RLJ
$1.65B
| $1.07M | ﹤0.01% |
97,227
+1,165
| +1% | +$15.2K |
|
|
SEI
1394
Solaris Energy Infrastructure
SEI
$3.87B
| $1.07M | ﹤0.01% |
98,344
-10,929
| -10% | -$132K |
|
1395
RH
RH
$3.46B
| $1.07M | ﹤0.01% |
5,085
+1,508
| +42% | +$448K |
|
|
ACH
1396
Accendra Health
ACH
$96.5M
| $1.07M | ﹤0.01% |
33,891
+3,346
| +11% | +$121K |
|
1397
Equity Bancshares
EQBK
$1.06B
| $1.06M | ﹤0.01% |
36,528
+21,247
| +139% | +$665K |
|
1398
e.l.f. Beauty
ELF
$5.61B
| $1.06M | ﹤0.01% |
34,647
+3,257
| +10% | +$81.8K |
|
1399
Scholastic
SCHL
$780M
| $1.06M | ﹤0.01% |
29,563
-5,846
| -17% | -$216K |
|
1400
Onto Innovation
ONTO
$15.7B
| $1.06M | ﹤0.01% |
15,215
-4,246
| -22% | -$314K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.